Reproductive BioMedicine Online
Volume 19, Issue 5 , Pages 638-659, November 2009

Oxidative stress and medical antioxidant treatment in male infertility

  • Francesco M Lanzafame

      Affiliations

    • Territorial Center of Andrology, AUSL 8, via Brenta 1, 96100 Syracuse, Italy
  • ,
  • Sandro La Vignera

      Affiliations

    • Section of Endocrinology, Andrology and Internal Medicine and Master in Andrological and Human Reproduction Sciences, Department of Biomedical Sciences, University of Catania, Piazza S. Maria di Gesù, 95123 Catania, Italy
  • ,
  • Enzo Vicari

      Affiliations

    • Section of Endocrinology, Andrology and Internal Medicine and Master in Andrological and Human Reproduction Sciences, Department of Biomedical Sciences, University of Catania, Piazza S. Maria di Gesù, 95123 Catania, Italy
  • ,
  • Aldo E Calogero

      Affiliations

    • Section of Endocrinology, Andrology and Internal Medicine and Master in Andrological and Human Reproduction Sciences, Department of Biomedical Sciences, University of Catania, Piazza S. Maria di Gesù, 95123 Catania, Italy
    • Correspondence:

Received 1 February 2009; received in revised form 1 April 2009; accepted 16 July 2009. published online 02 August 2010.

Declaration: The authors report no financial or commercial conflicts of interest.

Abstract 

Oxidative stress (OS) has been recognized as one of the most important cause of male infertility. Despite the antioxidant activity of seminal plasma, epididymis and spermatozoa, OS damages sperm function and DNA integrity. Since antioxidants suppress the action of reactive oxygen species, these compounds have been used in the medical treatment of male infertility or have been added to the culture medium during sperm separation techniques. Nevertheless, the efficacy of such a treatment has been reported to be very limited. This may relate to: (i) patient selection bias; (ii) late diagnosis of male infertility; (iii) lack of double-blind, placebo-controlled clinical trial; and/or (iv) use of end-points that are not good markers of the presence of OS. This review considers the effects of the main antioxidant compounds used in clinical practice. Overall, the data published suggest that no single antioxidant is able to enhance fertilizing capability in infertile men, whereas a combination of them seems to provide a better approach. Taking into account the pros and the cons of antioxidant treatment of male infertility, the potential advantages that it offers cannot be ignored. Therefore, antioxidant therapy should remain in the forefront of preventive medicine, including human reproductive medicine.

Keywords: antioxidant treatment, male infertility, oxidative stress, spermatozoa

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr Francesco Lanzafame, MD, is board certified in Endocrinology from the University of Catania, Italy. From 1992 to 1993, he was a research fellow at Guy’s Hospital, London, UK (Department of Obstetrics and Gynaecology, Fertility Unit directed by Professor M Chapman). From 1993 to 1994, he was research fellow at the Medical Research Council, Reproductive Biology Unit, directed by Professor J Aitken, Edinburgh, UK. In 1998, he followed a post-graduate course in Andrology, University of Florence, Italy. Since 2008, Dr Lanzafame assumed responsibility of the Andrology service at AUSL 8, Syracuse, Italy.Dr Francesco Lanzafame

PII: S1472-6483(09)00078-9

doi:10.1016/j.rbmo.2009.09.014

Reproductive BioMedicine Online
Volume 19, Issue 5 , Pages 638-659, November 2009